% of Cases treated with Surgery
| Country average (population) | Country average (country) | England | Scotland | Northern Ireland | Wales | |
|---|---|---|---|---|---|---|
| All invasive xnmsc | 44.8% | 40.3% | 46.2% | 36.3% | 38.6% | 40.1% |
| All xnmsc 0-24 | 48.3% | 45.5% | 48.6% | 47.5% | 30.6% | 55.2% |
| All xnmsc 25-59 | 62.2% | 58.4% | 63.2% | 57.3% | 52.8% | 60.5% |
| All xnmsc 60-79 | 44.9% | 39.5% | 46.6% | 34.8% | 37.7% | 38.8% |
| All xnmsc 80+ | 27.1% | 23.7% | 28.3% | 17.6% | 25.2% | 23.5% |
| Haematology | 5.5% | 3.9% | 5.8% | 3.7% | 0.5% | 5.6% |
| Head and Neck | 49.0% | 42.3% | 51.3% | 37.2% | 39.9% | 41.0% |
| Lower GI | 63.1% | 62.2% | 64.0% | 52.1% | 69.9% | 62.9% |
| Upper GI | 35.8% | 31.1% | 38.7% | 13.2% | 46.2% | 26.2% |
| HPB | 30.2% | 24.5% | 32.8% | 7.5% | 35.8% | 22.0% |
| Trachea, Bronchus & Lung | 24.1% | 15.1% | 26.9% | 12.4% | 9.2% | 12.0% |
| Melanoma of skin | 94.3% | 87.0% | 94.9% | 96.4% | 61.1% | 95.6% |
| Breast | 70.8% | 71.8% | 70.5% | 72.2% | 73.7% | 70.8% |
| Cervix | 57.1% | 45.3% | 60.1% | 42.1% | 32.9% | 46.2% |
| Other Female Genitals | 70.2% | 64.6% | 71.5% | 62.4% | 57.0% | 67.4% |
| Prostate | 18.9% | 12.8% | 20.4% | 12.2% | 6.0% | 12.5% |
| Kidney | 48.2% | 46.7% | 49.2% | 39.5% | 54.7% | 43.6% |
| Bladder | 81.1% | 81.9% | 81.1% | 78.3% | 85.8% | 82.5% |
| Brain and CNS | 45.3% | 42.0% | 45.9% | 48.7% | 37.6% | 36.1% |
| Thyroid & other endocrine glands | 80.6% | 66.3% | 83.7% | 74.5% | 22.5% | 84.5% |
| CUP | 8.4% | 7.0% | 9.5% | 2.3% | 12.7% | 3.6% |
| Other invasive cancer | 53.4% | 46.5% | 55.4% | 42.6% | 41.0% | 47.1% |
| Breast in situ | 82.1% | 83.2% | 81.8% | 86.2% | 83.0% | 81.6% |
| Cervix in situ | 85.5% | 67.1% | 88.1% | 96.4% | 12.8% | 71.4% |
| Other tumours | 58.9% | 52.0% | 60.1% | 67.4% | 21.0% | 59.5% |
| Non-Melanoma Skin Cancer | 47.6% | 55.6% | 44.0% | 90.3% | 44.2% | 44.0% |